Munich · Pre-Seed–Series A · 4 people tracked
Investment thesis
CARMA FUND I invests early in Life Science and Healthcare companies and projects, aiming to help translate scientific innovation toward market entry. It targets therapeutics, diagnostics, medical devices, and digital health, as well as R&D tools and platform technologies. The fund positions itself as an active partner offering an extra-long term horizon, flexible investment modes, and close relationships with technology transfer offices and industry partners. It sees Europe as home to a strong therapeutics industry with experienced entrepreneurs and leading scientists, and welcomes funding applications from all European sources, addressing the specialist capital needs of biotech and healthcare innovators.
Source: firm website, verified Aug 3, 2026.
Team · 4 people
from public directories
What they invest in
from 3 of 5 portfolio companiesDigital Health ×3Biotech ×2Healthtech ×2Data & Infrastructure ×1Deep Tech ×1Medical Devices ×1Mental Health ×1
HQs:Germany×2
Investments · 5 tracked
founders shown can be your intro pathA private biotech company developing crosslinked helix dimers as therapeutics targeting intracellular protein-protein interactions.
Co-investorsBioMedPartners
Elkedonia is developing a novel antidepressant aimed at patients who do not respond to current depression treatments, using a precision medicine approach.
BiotechDigital HealthMental Health
Co-investorsAngelini VenturesKurma Partners
Dimericon Therapeutics is a biotech company developing crosslinked helix dimers ("Dimericons") as therapeutics and as templates for small-molecule development, targeting hard-to-drug intracellular protein-protein interactions.
BiotechDeep TechDigital HealthHealthtechMedical DevicesMunich, DE
BoardChristian Leikert(Managing Partner)inDr. Martin Raditsch(Managing Partner)in
Company developing novel TNF-targeting antibodies with selective epitope technology for improved therapeutic benefit-risk profiles and bispecific therapies.
Co-investorsBioMedPartners
Thryve provides a plug-and-play API platform that integrates health data from over 500 wearable devices and health ecosystems, harmonizing fragmented data into standardized insights for healthcare providers and digital health partners.
Data & InfrastructureDigital HealthHealthtechBerlin, DE
Co-investorsKickstart Innovation
Portfolio news
latest coverage across their companiesElkedonia · fenomstalent.com · Jul 12, 2025
Frequently asked questions
- How many investments has CARMA FUND made?
- CARMA FUND has 5 tracked investments.
- What stage does CARMA FUND invest at?
- CARMA FUND invests at the Pre-Seed, Seed, Series A stages.
- What sectors does CARMA FUND focus on?
- CARMA FUND focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is CARMA FUND located?
- CARMA FUND is headquartered in Munich, DE.
- Who does CARMA FUND co-invest with?
- CARMA FUND most often shares deals with BioMedPartners, Angelini Ventures, Kickstart Innovation, among 4 tracked co-investors.
Images
.jpg)
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.